- 301. adenosine kinase
- [An enzyme that catalyzes the formation of ADP plus AMP from adenosine plus ATP. It can serve as a salvage mechanism for returning adenosine to nucleic acids. EC 2.7.1.20. ( MSH )] (UMLS (CSP) C0001464) =Amino Acid, Peptide, or Protein; Enzyme ;
| - 351. ADF
- [ATL Derived Factor (thioredoxin) appears to be a cytokine as well as an oxidoreductase involved in redox reactions through reversible oxidation of its active center dithiol to a disulfide, catalyzing dithiol-disulfide exchange reactions. It is ubiquitous, found in many organisms from plants and bacteria to mammals, and appears to have multiple substrates, including ribonuclease, choriogonadotropins, coagulation factors, glucocorticoid receptor, and insulin. ATL Derived Factor augments expression of the IL2R, TAC (IL2R/P55). (from OMIM 187700, Swiss-Prot P10599, and NCI) ( NCI )] (UMLS (NCI) C1504637) Adult T Cell Leukemia-Derived Factor;
ATL Derived Factor;
ATL Derived Factor/Human Thioredoxin;
Human Thioredoxin;
SASP;
Surface Associated Sulphydryl Protein;
TXN;
=Amino Acid, Peptide, or Protein; Biologically Active Substance ;
|
- 302. adenosine monophosphate
- [nucleotide found in muscle cells and important in metabolism; reversibly converted to ADP and ATP. ( CSP )] (UMLS (CSP) C0001465) =Nucleic Acid, Nucleoside, or Nucleotide; Biologically Active Substance ;
| - 352. ADH
- [octapeptide antidiuretic hormones released by the neurohypophysis of vertebrates; they control water metabolism and balance, contract smooth muscles, and may also be neurotransmitters. ( CSP )] (UMLS (CSP) C1705480) ADH (antidiuretic hormone);
antidiuretic hormone;
VASOPRESSIN;
VASOPRESSIN PREPARATION;
Vasopressins;
=Amino Acid, Peptide, or Protein; Pharmacologic Substance; Hormone =neuropeptide;
oligopeptide;
[HS702] POSTERIOR PITUITARY;
=ADH;
1-Deamino-8-D-arginine Vasopressin;
LYPRESSIN;
OXT;
VASOPRESSIN TANNATE (IN OIL);
VASOPRESSIN 20 UNT/ML |
- 303. Adenosine Nucleotide Transporter
- [The most abundant mitochondrial protein, Adenine Nucleotide Translocator (ANT), is a homodimer of 30-kD subunits embedded asymmetrically in the inner mitochondrial membrane that forms a gated pore through which ADP is moved from the matrix to the cytoplasm. ( NCI )] (UMLS (NCI) C1332170) =Amino Acid, Peptide, or Protein; Biologically Active Substance
| - 353. ADH
- [usual mammalian antidiuretic hormone, it is a cyclic peptide with arginine in position 8 of the chain. ( CSP )] (UMLS (NCI) C0003779) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Hormone
|
- 304. adenosine receptor
- [One of the purinergic P1 receptors that prefers adenosine to other endogenous purines. ( NCI )] (UMLS (CSP) C0001471) =Amino Acid, Peptide, or Protein; Receptor ;
| - 354. ADH
- [This protein is a precursor protein consisting of arginine vasopressin and two associated proteins, neurophysin II and a glycopeptide, copeptin. Arginine vasopressin is a posterior pituitary hormone which is synthesized in the supraoptic nucleus and paraventricular nucleus of the hypothalamus. Along with its carrier protein, neurophysin II, it is packaged into neurosecretory vesicles and transported axonally to the nerve endings in the neurohypophysis where it is either stored or secreted into the bloodstream. It has a direct antidiuretic action on the kidney, and also causes vasoconstriction of the peripheral vessels. This hormone can contract smooth muscle during parturition and lactation. It is also involved in cognition, tolerance, adaptation and complex sexual and maternal behaviour, as well as in the regulation of water excretion and cardiovascular functions. (from LocusLink) ( NCI )] (UMLS (NCI) C0138318) =Amino Acid, Peptide, or Protein; Neuroreactive Substance or Biogenic Amine; Hormone
|
- 305. Adenosine Triphosphatase
- [in addition to the classic mitochondrial enzyme, many structural (e.g. myosin) and transport (e.g. ion pump) proteins include an ATPase domain. ( CSP )] (UMLS (NCI) C0001473) =Amino Acid, Peptide, or Protein; Enzyme ;
| - 355. ADH
- (UMLS (NCI) C1332347) Atypical Breast Ductal Hyperplasia;
Atypical Ductal Breast Hyperplasia;
Atypical Ductal Hyperplasia of Breast;
Atypical Ductal Hyperplasia of the Breast;
DIN 1B;
Ductal Intraepithelial Neoplasia, Grade 1B =Neoplastic Process |
- 306. adenosine triphosphate
- [adenine nucleotide containing three phosphate groups esterified to the sugar moiety; in addition to its crucial roles in metabolism adenosine triphosphate is a neurotransmitter. ( CSP )] (UMLS (CSP) C0001480) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance; Biologically Active Substance
| - 356. Adhere
- [Cause to be firmly attached; stick or hold together and resist separation. ( NCI )] (UMLS (NCI) C0231441) =Finding
|
- 307. Adenosine, 3'-((2-amino-3-(4-methoxyphenyl)-1-oxopropyl)amino)-3'-deoxy-N,N-dimethyl-, (S)-
- [antibiotic produced by Streptomyces alboniger, used as an antineoplastic and antitrypanosomal agent and in research as an inhibitor of protein synthesis. ( CSP )] (UMLS (NCI) C0034145) =Nucleic Acid, Nucleoside, or Nucleotide; Antibiotic =antineoplastic antibiotics;
Antiprotozoal Agent;
nucleoside analog;
| - 357. Adherence
- [The act of abiding by a stated treatment plan or protocol. ( NCI )] (UMLS (NCI) C1510802) =Functional Concept ;
|
- 308. Adenosis of Breast
- [A benign lesion of the BREAST, characterized by a proliferation of disorganized small glands lined by EPITHELIAL CELLS without apparent myoepithelial cells. These glands usually have enlarged lumens, and lie in adipose or fibrous tissue. ( MSH )] (UMLS (NCI) C0085750) =Neoplastic Process ;
| - 358. Adherence Syndrome
- (UMLS (NCI) C1332173) =Disease or Syndrome
|
- 309. Adenosquamous Bile Duct Carcinoma
- (UMLS (NCI) C0861854) Adenosquamous Carcinoma of Bile Duct;
Adenosquamous Carcinoma of the Bile Duct;
Bile Duct Adenosquamous Carcinoma;
=Neoplastic Process | - 359. Adherens Junction
- [The best understood cell-cell junction required for adhesion between cells in the epithelium. It seals adjacent epithelial cells together, preventing the passage of most dissolved molecules from one side of the epithelial sheet to the other. Adherens junctions are located most apically in insect cells and just basal to the tight junction in vertebrate cells. It is formed by the fusion of adjacent cell membranes which encircle the apical cell surface like a belt or fence based on homophilic association between molecules of the transmembrane protein E-cadherin, which is linked on its cytoplasmic side to the actin cytoskeleton via b-catenin (Drosophila Armadillo) and a-catenin. The adherens junctions and associated cytoskeleton form a continuous band (zonula adherens) around the apical circumference of each cell, thus uniting the cells of the epithelium into a coherent sheet. ( NCI )] (UMLS (NCI) C0230613) =Cell Component
|
- 310. Adenosquamous Breast Carcinoma
- [An invasive breast carcinoma characterized by the presence of tubular and glandular neoplastic cell structures, admixed with islands of neoplastic cells showing squamous differentiation. ( NCI )] (UMLS (NCI) C1510796) =Neoplastic Process ;
| - 360. Adherent Culture
- [A type of culture in which cells grow as a monolayer that is attached to the tissue culture flask. ( NCI )] (UMLS (NCI) C1510803) Monolayer culture;
=Laboratory Procedure ;
|
- 311. Adenosquamous Carcinoma
- [A carcinoma composed of malignant glandular cells and malignant squamous cells. ( NCI )] (UMLS (NCI) C0206623) =Neoplastic Process ;
=carcinoma;
Neoplasms, Complex and Mixed | - 361. adherent junction
- [ ] (UMLS (CSP) C0872093) =Body Space or Junction ;
|
- 312. Adenosquamous Carcinoma of Colon
- (UMLS (NCI) C1333082) Adenosquamous Carcinoma of the Colon;
Adenosquamous Colon Carcinoma;
Colon Adenosquamous Carcinoma;
Colonic Adenosquamous Carcinoma =Neoplastic Process ;
| - 362. ADHERENT LEUCOMA
- [ ] (UMLS (ICD9CM) C0271275) =Finding
|
- 313. Adenosquamous Carcinoma of Gallbladder
- (UMLS (NCI) C1333741) Adenosquamous Carcinoma of the Gallbladder;
Gallbladder Adenosquamous Carcinoma =Neoplastic Process ;
| - 363. Adhering Junction
- [Anchoring junctions typically are observed as "spot welds" between cells in many types of epithelia. Detail structures can be seen only with EM. ( NCI )] (UMLS (NCI) C0887872) Adhesive Junction;
Anchoring Junction;
=Cell Component |
- 314. Adenosquamous Carcinoma of Pancreas
- (UMLS (NCI) C1335299) Adenosquamous Carcinoma of the Pancreas;
Pancreatic Adenosquamous Carcinoma =Neoplastic Process ;
| - 364. adhesin
- [family of bacterial surface proteins involved in receptor-specific binding of bacteria to target cells, the first step in infection. ( CSP )] (UMLS (CSP) C0243040) =Amino Acid, Peptide, or Protein; Immunologic Factor =bacterial protein;
|
- 315. Adenosquamous Carcinoma of Prostate
- [An infrequent invasive carcinoma of the prostate gland characterized by the presence of both glandular and squamous neoplastic components. It is more often located in the transitional zone of the prostate gland and it tends to rapidly metastasize to the bones. ( NCI )] (UMLS (NCI) C1335503) Adenosquamous Carcinoma of the Prostate;
Prostate Adenosquamous Carcinoma;
=Neoplastic Process | - 365. ADHESIOLYSIS MUS/TEN/FAS
- [ ] (UMLS (ICD9CM) C0177642) =Therapeutic or Preventive Procedure
|
- 316. Adenosquamous Carcinoma of Stomach
- [A carcinoma that combines an adenocarcinoma and squamous cell carcinoma. — 2003 ( NCI )] (UMLS (NCI) C1333761) Adenosquamous Carcinoma of the Stomach;
Gastric Adenosquamous Carcinoma =Neoplastic Process | - 366. ADHESIOLYSIS OVARY/TUBE
- [ ] (UMLS (ICD9CM) C0376032) =Therapeutic or Preventive Procedure
|
- 317. Adenosquamous Carcinoma of the Mouse Pulmonary System
- (UMLS (NCI) C1510797) =Neoplastic Process ;
| - 367. adhesion
- [union of opposing surfaces. ( CSP )] (UMLS (CSP) C0175633) =Natural Phenomenon or Process ;
=Physical Phenomenon;
|
- 318. Adenosquamous Carcinoma of the Thymus
- (UMLS (NCI) C1332171) Adenosquamous Carcinoma of Thymus;
Thymic Adenosquamous Carcinoma;
Thymus Adenosquamous Carcinoma;
=Neoplastic Process ;
| - 368. Adhesion
- [Pathological processes consisting of the union of the opposing surfaces of a wound. ( MSH )] (UMLS (NCI) C0001511) =Acquired Abnormality ;
|
- 319. Adenosquamous Cell Carcinoma in situ of Lung
- [A non-small cell lung cancer (NSCLC), histologically classified as adenosquamous carcinoma. Carcinoma in situ with no regional lymph node metastasis and no distant metastasis (Tis, N0, M0). (AJCC 6th Ed.) - 2003 ( NCI )] (UMLS (NCI) C0854971) Adenosquamous Cell Carcinoma in situ of the Lung;
Lung Adenosquamous Cell Carcinoma in situ;
Stage 0 Adenosquamous Cell Carcinoma of Lung;
Stage 0 Adenosquamous Cell Carcinoma of the Lung;
Stage 0 Adenosquamous Cell Lung Carcinoma;
Stage 0 Adenosquamous Lung Carcinoma =Neoplastic Process | - 369. Adhesion Factor Degradation
- [By induction of conjugation, transport, oxidation, and/or proteolysis, Adhesion Factor Degradation consists of breakdown of members of the class of cell surface proteins involved in cell-cell or cell-matrix attachment. ( NCI )] (UMLS (NCI) C1510804) =Physiologic Function ;
|
- 320. Adenosquamous Cell Carcinoma of Cervix
- (UMLS (NCI) C0346202) =Neoplastic Process
| - 370. Adhesion Factor Production
- [Adhesion Factor Production consists of synthesis of cell surface proteins involved in cell-cell or cell-matrix attachment. Such synthesis can alter maintenance of tissue integration, wound healing, cellular migrations, and metastasis. ( NCI )] (UMLS (NCI) C1510805) =Physiologic Function ;
|
- 321. Adenosquamous Cell Carcinoma of the Mouse Oral Cavity
- (UMLS (NCI) C1510798) =Neoplastic Process ;
| - 371. Adhesion Factor Stabilization
- [Adhesion Factor Stabilization inhibits conjugation, transport, oxidation, or proteolysis of cell surface proteins involved in cell-cell or cell-matrix attachment. Such stabilization can alter maintenance of tissue integration, wound healing, cellular migrations, and metastasis. ( NCI )] (UMLS (NCI) C1510806) =Physiologic Function ;
|
- 322. Adenosquamous Cell Lung Carcinoma
- [An aggressive carcinoma with a poor prognosis characterized by a presence of both malignant squamous cells and glandular cells. (NCI05) ( NCI )] (UMLS (NCI) C0279557) =Neoplastic Process
| - 372. Adhesion Factor Suppression
- [By decreased production or increased degradation, Adhesion Factor Suppression consists of interference with, or restraint of, the expression or activity of cell surface proteins involved in cell-cell or cell-matrix attachment. Such suppression alters maintenance of tissue integration, wound healing, cellular migrations, and metastasis. ( NCI )] (UMLS (NCI) C1510807) =Physiologic Function ;
|
- 323. Adenosquamous Cell Lung Carcinoma Recurrent
- [The reemergence of adenosquamous lung carcinoma after a period of remission. (NCI05) ( NCI )] (UMLS (NCI) C0854970) Recurrent Adenosquamous Cell Carcinoma of Lung;
Recurrent Adenosquamous Cell Carcinoma of the Lung;
Recurrent Adenosquamous Cell Lung Carcinoma;
Recurrent Adenosquamous Lung Carcinoma =Neoplastic Process | - 373. Adhesion Molecule
- [diverse family of extracellular (e.g., laminin) and cell surface (e.g., NCAM) glycoproteins involved in cell-cell and cell-extracellular matrix adhesion, recognition, activation, and migration. ( CSP )] (UMLS (NCI) C0007578) =Amino Acid, Peptide, or Protein; Biologically Active Substance =glycoprotein;
=cadherin;
CIG;
laminin;
leukocyte adhesion molecule;
B3 antigen;
Complement S-Protein;
Osteopontin;
Cytotacin;
Thrombospondin;
CD106;
paxillin;
CD56;
Selectin |
- 324. adenosylcobalamin
- [ ] (UMLS (CSP) C0056039) =Organic Chemical; Pharmacologic Substance ;
=[VT101] CYANOCOBALAMIN;
cofactor =cobamide | - 374. ADHESION TYMP-PROMONTOR
- [ ] (UMLS (ICD9CM) C0155482) =Disease or Syndrome; Anatomical Abnormality
|
- 325. ADENOVIRAL CONJUNCT NEC
- [ ] (UMLS (ICD9CM) C0153110) =Disease or Syndrome
| - 375. ADHESION TYMPANUM-INCUS
- [ ] (UMLS (ICD9CM) C0155480) =Disease or Syndrome; Anatomical Abnormality
|
- 326. ADENOVIRAL MENINGITIS
- [ ] (UMLS (ICD9CM) C0153015) =Disease or Syndrome
| - 376. ADHESION TYMPANUM-STAPES
- [ ] (UMLS (ICD9CM) C0155481) =Disease or Syndrome; Anatomical Abnormality
|
- 327. ADENOVIRAL PNEUMONIA
- [ ] (UMLS (ICD9CM) C0276156) =Disease or Syndrome
| - 377. Adhesions and ankylosis (bony or fibrous)
- [ ] (UMLS (ICD9CM) C0155942) =Disease or Syndrome; Anatomical Abnormality
|
- 328. Adenoviral Vector
- [One of a number of genetically-engineered adenoviruses designed to insert a gene of interest into a eukaryotic cell where the gene of interest is subsequently expressed. Unlike most other vectors, adenovirus vectors have the ability to infect post-mitotic cells. Thus, these agents are especially useful for gene transfer into neuronal cells. (NCI04) ( NCI )] (UMLS (NCI) C1510800) Adenovirus Vector;
=Nucleic Acid, Nucleoside, or Nucleotide ;
| - 378. Adhesions and disruptions of iris and ciliary body
- [ ] (UMLS (ICD9CM) C0154932) =Disease or Syndrome; Anatomical Abnormality
|
- 329. Adenoviridae
- [nonenveloped, ds-DNA in single linear molecule, at least 10 polypeptides, assembly of virus particle in nucleus of usually one host, transmission by direct or indirect contact with urine or feces in throat or eye. ( CSP )] (UMLS (CSP) C0001483) =Virus
| - 379. Adhesions and disruptions of pupillary membranes
- [ ] (UMLS (ICD9CM) C0154935) =Disease or Syndrome; Anatomical Abnormality
|
- 330. Adenoviridae vaccine
- [ ] (UMLS (CSP) C0597766) =Organic Chemical ;
| - 380. ADHESIONS OF IRIS NOS
- [ ] (UMLS (ICD9CM) C0154933) =Disease or Syndrome; Anatomical Abnormality
|
- 331. Adenovirus 5-Tumor Necrosis Factor Alpha/Capecitabine
- (UMLS (NCI) C1328076) =Therapeutic or Preventive Procedure ;
| - 381. ADHESIVE CAPSULIT SHLDER
- [ ] (UMLS (ICD9CM) C0311223) =Disease or Syndrome
|
- 332. Adenovirus B7-1
- [A gene-viral vector complex comprised of an adenovirus vector and B7-1 gene targeting the CD80 antigen. Adenovirus B7-1 is used as a component in antineoplastic vaccines to elicit a cytotoxic T-cell response. (NCI04) ( NCI )] (UMLS (NCI) C0879611) =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
| - 382. ADHESIVE MID EAR DIS NEC
- [ ] (UMLS (ICD9CM) C0155483) =Disease or Syndrome; Anatomical Abnormality
|
- 333. Adenovirus Death Protein
- [An adenovirus nuclear membrane glycoprotein synthesized from the E3 transcription unit in large amounts late in infection. It is required for efficient lysis of infected cells. It is being investigated for use in targeting tumors for death by a suicide mechanism. ( NCI )] (UMLS (NCI) C0389931) =Amino Acid, Peptide, or Protein; Biologically Active Substance
| - 383. ADHESIVE MID EAR DIS NOS
- [ ] (UMLS (ICD9CM) C0155478) =Disease or Syndrome ;
|
- 334. Adenovirus E1A Protein
- [Proteins transcribed from the E1A region of adenovirus which are involved in positive regulation of transcription of the early genes. (MSH2001) ( NCI )] (UMLS (NCI) C0101583) =Amino Acid, Peptide, or Protein; Immunologic Factor ;
| - 384. ADHESIVE PERICARDITIS
- (UMLS (ICD9CM) C0152452) =Disease or Syndrome
|
- 335. Adenovirus E1B Protein
- [Human E1B protein (175 aa, 20 kDa) protein is encoded by the human adenovirus 2 (HadV-2) gene. This protein is transcribed by the E1B region of the HadV-2 gene, which is involved in the regulation of E1B protein levels. This protein is an inhibitor of apoptosis induced by TNF or FAS pathways, as well as p53-mediated apoptosis. Without E1B function, virus production is compromised due to the premature death of the host cell. ( NCI )] (UMLS (NCI) C0101584) =Amino Acid, Peptide, or Protein; Immunologic Factor ;
| - 385. Adiaphoresis
- (UMLS (NCI) C0003028) =Disease or Syndrome ;
|
- 336. Adenovirus E1b19k-Binding Protein B5
- [BCL2/Adenovirus E1B 19kd Interacting Protein 3-Like, encoded by the BNIP3L gene, is a member of the BCL2/adenovirus E1B 19 kD-interacting protein (BNIP) family. It promotes apoptosis by interacting with the antiapoptotic E1B 19 kDa protein which is responsible for the protection of virally-induced cell death, as well as cellular antiapoptotic proteins Bcl2 and Bcl2L1. It can overcome the suppressor bcl-2 and bcl-xl, although high levels of bcl-xl expression will inhibit apoptosis. This protein is a functional homolog of BNIP3, a proapoptotic protein, and may function simultaneously with BNIP3. It may play a role in tumor suppression. (From LocusLink) ( NCI )] (UMLS (NCI) C0662972) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 386. adipex P
- [ ] (UMLS (CSP) C0001520) =Organic Chemical; Pharmacologic Substance
|
- 337. ADENOVIRUS INFECT NOS
- (UMLS (ICD9CM) C0001485) =Disease or Syndrome
| - 387. Adipiodone, Dimeglumine Salt
- [The meglumine salt form of iodipamide, a triiodinated benzoate derivative, and an ionic dimeric contrast agent used in diagnostic imaging. When administered in vivo, iodipamide is removed from the liver and secreted into the biliary tract. Like other organic iodine compounds, this agent blocks x-ray and appears opaque on x-ray film; thereby enhancing the visibility of the bile ducts and gallbladder during cholangiography and cholecystography procedures. ( NCI )] (UMLS (NCI) C0065885) =Organic Chemical; Indicator, Reagent, or Diagnostic Aid ;
=IODIPAMIDE;
=IODIPAMIDE MEGLUMINE 26.8 %;
IODIPAMIDE MEGLUMINE 52 %;
IODIPAMIDE MEGLUMINE 10.3 %;
|
- 338. Adenovirus Protein
- (UMLS (NCI) C1332172) =Amino Acid, Peptide, or Protein; Biologically Active Substance
| - 388. adipocyte
- [fat-storing cells found mostly in the abdominal cavity and subcutaneous tissue. ( CSP )] (UMLS (CSP) C0206131) =Cell ;
=adipose fat body;
Connective and Soft Tissue Cell |
- 339. Adenovirus RSV-TK
- [A gene viral vector complex comprised of a replication-defective adenovirus and a herpes simplex virus thymidine kinase gene that activates ganciclovir, causing inhibition of DNA synthesis and apoptosis. ( NCI )] (UMLS (NCI) C0879467) =Nucleotide Sequence ;
| - 389. Adipocyte with Nuclear Atypia
- (UMLS (NCI) C1510808) =Cell
|
- 340. adenovirus, NOS1
- (UMLS (HL7) C1548490) =Pharmacologic Substance; Immunologic Factor ;
=Vaccines administered (code = CVX)(parenteral, unless oral is noted);
| - 390. adipogenesis
- [The production of fat, either fatty degeneration or fatty infiltration; also applied to the normal deposition of fat or to the conversion of carbohydrate or protein to fat. ( NCI )] (UMLS (CSP) C0596843) =Molecular Function
|
- 341. adenovirus, type 4
- [adenovirus vaccine, type 4, live, oral ( HL7V3.0 )] (UMLS (HL7) C0695129) =Pharmacologic Substance; Immunologic Factor =Vaccines administered (code = CVX)(parenteral, unless oral is noted);
VaccineType | - 391. Adipogenesis Inhibitory Factor
- [cloned from a primate stromal cell line; plays a role in megakaryocyte proliferation and B cell differentiation. ( CSP )] (UMLS (NCI) C0083031) =Amino Acid, Peptide, or Protein; Immunologic Factor ;
=Cytokine;
|
- 342. adenovirus, type 7
- [adenovirus vaccine, type 7, live, oral ( HL7V3.0 )] (UMLS (HL7) C0695130) =Pharmacologic Substance; Immunologic Factor =Vaccines administered (code = CVX)(parenteral, unless oral is noted);
VaccineType | - 392. Adipogenesis Inhibitory Factor
- [(in-ter-LOO-kin) IL-11. A type of biological response modifier (a substance that can improve the body's natural response to infection and disease) that stimulates immune response and may reduce toxicity to the gastrointestinal system resulting from cancer therapy. These substances are normally produced by the body. They are also made in the laboratory for use in treating cancer and other diseases. Also called oprelvekin. ( NCI )] (UMLS (NCI) C0537670) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor =Recombinant Protein;
[BL400] BLOOD FORMATION PRODUCTS =OPRELVEKIN 5 MG |
- 343. Adenovirus-L523S Vaccine/L523S DNA Vaccine
- (UMLS (NCI) C1328163) L523S Vaccine =Therapeutic or Preventive Procedure; ;
| - 393. adiponectin
- [peptide hormone produced by adipocytes, involved in glucose and lipid regulation. ( CSP )] (UMLS (CSP) C0389071) =Amino Acid, Peptide, or Protein; Biologically Active Substance =Peptide Hormone;
|
- 344. adenylate
- [ ] (UMLS (CSP) C0597765) =Nucleic Acid, Nucleoside, or Nucleotide; Biologically Active Substance
| - 394. adipose fat body
- [connective tissue composed of fat cells lodged in the meshes of areolar tissue. ( CSP )] (UMLS (CSP) C0001527) =Tissue ;
|
- 345. Adenylate Cyclase-Inhibiting G Alpha Protein
- [the alpha subunit of the G(i) (or G inhibitory) class of heterotrimeric G proteins. ( NCI )] (UMLS (NCI) C1333649) G Protein Alpha Inhibiting Polypeptide;
G(i) Alpha;
G(i) Alpha Protein =Amino Acid, Peptide, or Protein; Enzyme | - 395. Adipose Tissue Neoplasm
- [A benign or malignant tumor composed of adipose (fatty) tissue. — 2003 ( NCI )] (UMLS (NCI) C0206631) =Neoplastic Process =Connective and Soft Tissue Neoplasm;
=AZALEKO LIPOMA;
Liposarcoma;
Angiolipoma;
Angiomyolipoma;
Adrenal Gland Myelolipoma |
- 346. adenylate deaminase
- [An enzyme that catalyzes the deamination of AMP to IMP. EC 3.5.4.6. ( MSH )] (UMLS (CSP) C0002651) =Amino Acid, Peptide, or Protein; Enzyme
| - 396. adiposity
- [The amount of fat or lipid deposit at a site or an organ in the body, an indicator of body fat status. ( MSH )] (UMLS (CSP) C1563743) =Organism Attribute; ;
|
- 347. adenylate kinase
- [An enzyme that catalyzes the phosphorylation of AMP to ADP in the presence of ATP or inorganic triphosphate. EC 2.7.4.3. ( MSH )] (UMLS (CSP) C0001497) =Amino Acid, Peptide, or Protein; Enzyme
| - 397. adipsia
- [ ] (UMLS (CSP) C0277967) =Sign or Symptom
|
- 348. adenylated aminoacid
- [ ] (UMLS (CSP) C0599001) =Nucleic Acid, Nucleoside, or Nucleotide ;
| - 398. ADJ
- [Agents given to augment or stimulate a primary therapy or alleviate adverse effects caused by the primary therapy. ( NCI )] (UMLS (NCI) C0001552) =Chemical Viewed Functionally ;
|
- 349. adenylosuccinate synthase
- [A carbon-nitrogen ligase. During purine ribonucleotide biosynthesis, this enzyme catalyzes the synthesis of adenylosuccinate from GTP; IMP; and aspartate with the formation of orthophosphate and GDP. EC 6.3.4.4. ( MSH )] (UMLS (CSP) C0001503) =Amino Acid, Peptide, or Protein; Enzyme
| - 399. ADJ CEREBRAL VENT SHUNT
- [ ] (UMLS (ICD9CM) C0490028) =Finding
|
- 350. Adenylosuccinate Synthetase Inhibitor
- [Substances that inhibit Adenylosuccinate Synthetase, an enzyme involved in purine metabolism, and interferes with DNA, RNA, and ATP biosynthesis. ( NCI )] (UMLS (NCI) C1510801) Adenylosuccinate Synthetase Inhibitors;
=Pharmacologic Substance ;
| - 400. ADJ DIS-EMOTION/CONDUCT
- (UMLS (ICD9CM) C0001541) =Mental or Behavioral Dysfunction ;
|
home
